Inside the Rise of circRNA
Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality
07/09/2026
11 min read
False
Advertisement
Related Content
Cell & Gene
Development & Clinical
Business & Trends
The Biggest Bottlenecks Holding Back Cell and Gene Therapy
August 24, 2026
9 min read
Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges
Interviews
Business & Trends
What Pharma Can Learn From Military Intelligence
August 21, 2026
5 min read
Former military intelligence officer Tony Page discusses what pharma can learn from early warning systems, decision cycles, and the discipline of intelligence
Small Molecules
Drug Discovery
Development & Clinical
Musings from The Power List: Daniel Vitt
August 20, 2026
6 min read
From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development
Cell & Gene
Development & Clinical
Interviews
The Road to Commercial-Scale iPSC Cell Therapy
August 19, 2026
5 min read
Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?